Related Experiment Videos
Bifunctional antibodies for radioimmunotherapy
J F Chatal1, A Faivre-Chauvet, M Bardies
1INSERM Research Unit 211, Nantes, France.
Hybridoma
|April 1, 1995
Summary
This study introduces a two-step targeting technique using bifunctional antibodies for improved radioimmunotherapy. This method enhances tumor targeting and significantly reduces normal tissue radioactivity, showing promise for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Radiochemistry
Background:
- Two-step targeting utilizes bifunctional antibodies for enhanced tumor localization.
- Bispecific antibodies enable sequential delivery of targeting agents.
Purpose of the Study:
- To evaluate a two-step targeting technique using bifunctional antibodies for radioimmunotherapy.
- To assess tumor uptake and normal tissue radioactivity in cancer patients.
Main Methods:
- Administered a nonradiolabeled immunoconjugate followed by a radiolabeled hapten.
- Utilized an anti-CEA/anti-DTPA-indium bifunctional antibody and indium-111-labeled hapten.
- Compared results with directly labeled F(ab')2 fragments in colorectal and medullary thyroid cancer patients.
Main Results:
- Tumor uptake remained comparable to directly labeled antibodies.
- Normal tissue radioactivity was significantly reduced (3- to 6-fold).
- Achieved fast tumor uptake kinetics (hours) and high tumor-to-normal tissue ratios.
Conclusions:
- The bifunctional antibody technique offers favorable parameters for efficient radioimmunotherapy.
- This method improves tumor targeting specificity and reduces systemic toxicity.
- Demonstrated clinical efficacy in reducing off-target radiation exposure.